Article info
PDFCommentary
Non-invasive diagnosis of patients with ‘at-risk’ NAFLD : only fibrosis counts?
- Correspondence to Professor Andreas Geier, Division of Hepatology, University Hospital Würzburg, Würzburg 97080, Germany; geier_a2{at}medizin.uni-wuerzburg.de; geier_a2{at}ukw.de
Citation
Non-invasive diagnosis of patients with ‘at-risk’ NAFLD : only fibrosis counts?
Publication history
- Received March 3, 2020
- Revised March 19, 2020
- Accepted March 19, 2020
- First published March 27, 2020.
Online issue publication
June 06, 2020
Article Versions
- Previous version (27 March 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.